Transdermal drug delivery system is defined as topical administration which is available in form of patches. It is applied on intact skin at a predetermined and controlled rate. Transdermal drug delivery system provides various advantages over conventional routes as it provides a non-invasive alternative to parenteral routes. Furthermore, pharmacokinetic profiles of drugs are more uniform which in turn minimize the risk of side effects.
The global transdermal drug delivery system market report has been segmented on the basis of technology, application, and region. Advancements in transdermal technologies is major factors expected to drive the market growth over the forecast period. Increasing number of cases of chronic diseases globally is another factor expected to boost the growth of global transdermal drug delivery system market over the forecast period. Transdermal drug delivery system provides various advantages as compared to conventional drug delivery methods thus creating demand for the product over the forecast period.
Technology segment includes electroporation, radiofrequency, iontophoresis, microporation, thermal, mechanical arrays, and ultrasound. The microporation segment is expected to witness rapid growth rate over the forecast period. This is attributed to increasing number of product launches and robust product pipeline.
Do Inquiry of the Report Here: https://marketresearch.biz/report/transdermal-drug-delivery-system-market/#inquiry
Regional segmentation includes North America, Europe, Latin America, Asia Pacific and Middle East and Africa. North America contributes major market share and expected to maintain its dominance over the forecast period owing to the high adoption of advance technologies in the region. Asia Pacific region is expected to witness rapid growth rate over the forecast period. Countries like India, China, is expected to support the growth of Asia Pacific, owing to the increasing incidences of chronic diseases such as cardiovascular diseases, diabetes etc. in the region.
Some prominent players in the global transdermal drug delivery system market are Novartis AG, Johnson & Johnson, Mylan Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Biogel Technology, Inc., ProSolus, Inc., Sanofi SA, The 3M Company, Watson Pharmaceuticals, Inc., and Noven Pharmaceuticals, Inc.